• S 677: Exploring GLP-1: A Breakthrough in Neurodegenerative Disease Treatment?

  • May 20 2024
  • Length: 19 mins
  • Podcast

S 677: Exploring GLP-1: A Breakthrough in Neurodegenerative Disease Treatment?  By  cover art

S 677: Exploring GLP-1: A Breakthrough in Neurodegenerative Disease Treatment?

  • Summary

  • You've probably heard of GLP-1 agnostics (Ozempic) when it comes to weight loss and weight management but emerging research could point to an additional use for this class of drugs. In today's episode, we're going to look at GLP-1 use for neurodegenerative disease and it's potential treatment effects. I'll also discuss my history around this topic, the potential risks of using these drugs, and more. Topics include: - GLP-1 For Neurodegenerative Disease Treatment? - Alzheimer’s and Type 3 Diabetes - Insulin Sensitivity - 2022 Study - Personal History With This Topic - Risks of GLP-1’s - FNMS Program - Please Share, Rate, and Review ---------- Subscribe to My New Youtube Channel: https://youtube.com/@sammillerscience?si=s1jcR6Im4GDHbw_1 ---------- My Live Program for Coaches: The Functional Nutrition and Metabolism Specialization www.metabolismschool.com ---------- [Free] Metabolism School 101: The Video Series http://www.metabolismschool.com/metabolism-101 ---------- Grab a Copy of My New Book - Metabolism Made Simple ---------- Stay Connected: Instagram: @sammillerscience Youtube: SamMillerScience Facebook: The Nutrition Coaching Collaborative Community TikTok: @sammillerscience ---------- “This Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast and the show notes or the reliance on the information provided is to be done at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for educational purposes only. Always consult your physician before beginning any exercise program and users should not disregard, or delay in obtaining, medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. By accessing this Podcast, the listener acknowledges that the entire contents and design of this Podcast, are the property of Oracle Athletic Science LLC, or used by Oracle Athletic Science LLC with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this Podcast may save and use information contained in the Podcast only for personal or other non-commercial, educational purposes. No other use, including, without limitation, reproduction, retransmission or editing, of this Podcast may be made without the prior written permission of Oracle Athletic Science LLC, which may be requested by contacting the Oracle Athletic Science LLC by email at team@sammillerscience.com. By accessing this Podcast, the listener acknowledges that Oracle Athletic Science LLC makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in this Podcast."
    Show more Show less

What listeners say about S 677: Exploring GLP-1: A Breakthrough in Neurodegenerative Disease Treatment?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.